In contrast, only PALB2 and MSH2 displayed a substantial increase in mutation frequency among patients with a family history of PC, and only CHEK2, MSH2, and TP53 had increased frequencies of mutation among patients with PC with a family history of colorectal cancer (Table 3). Here, TP53 is linked to colorectal cancer.